{
    "protocolSection": {
        "identificationModule": {
            "nctId": "NCT05487235",
            "orgStudyIdInfo": {
                "id": "GO43712"
            },
            "secondaryIdInfos": [
                {
                    "id": "2021-006479-40",
                    "type": "EUDRACT_NUMBER"
                }
            ],
            "organization": {
                "fullName": "Genentech, Inc.",
                "class": "INDUSTRY"
            },
            "briefTitle": "A Study to Evaluate the Safety, Pharmacokinetics, and Activity of GDC-1971 in Combination With Atezolizumab in Participants With Locally Advanced or Metastatic Solid Tumors",
            "officialTitle": "A Phase Ib, Open-Label Study Evaluating the Safety, Pharmacokinetics, and Activity of GDC-1971 in Combination With Atezolizumab in Patients With Locally Advanced or Metastatic Solid Tumors",
            "therapeuticArea": [
                "Oncology and Hematology"
            ],
            "study": "a-study-to-evaluate-the-safety-pharmacokinetics-and-activity-of-gdc-in-combination-with-atezolizumab-in-participants-with-locally-advanced-or-metastatic-solid-tumors"
        },
        "statusModule": {
            "statusVerifiedDate": "2024-07",
            "overallStatus": "RECRUITING",
            "expandedAccessInfo": {
                "hasExpandedAccess": false
            },
            "startDateStruct": {
                "date": "2022-08-17",
                "type": "ACTUAL"
            },
            "primaryCompletionDateStruct": {
                "date": "2025-05-31",
                "type": "ESTIMATED"
            },
            "completionDateStruct": {
                "date": "2025-05-31",
                "type": "ESTIMATED"
            },
            "studyFirstSubmitDate": "2022-07-21",
            "studyFirstSubmitQcDate": "2022-08-02",
            "studyFirstPostDateStruct": {
                "date": "2022-08-04",
                "type": "ACTUAL"
            },
            "lastUpdateSubmitDate": "2024-07-03",
            "lastUpdatePostDateStruct": {
                "date": "2024-07-05",
                "type": "ACTUAL"
            }
        },
        "sponsorCollaboratorsModule": {
            "responsibleParty": {
                "type": "SPONSOR"
            },
            "leadSponsor": {
                "name": "Genentech, Inc.",
                "class": "INDUSTRY"
            }
        },
        "oversightModule": {
            "oversightHasDmc": false,
            "isFdaRegulatedDrug": true,
            "isFdaRegulatedDevice": false
        },
        "descriptionModule": {
            "briefSummary": "The purpose of this study is to evaluate the safety, pharmacokinetics (PK), and activity of GDC-1971 when administered in combination with atezolizumab in participants with locally advanced or metastatic solid tumors.\n\nThe study will have 2 stages- dose finding stage and expansion stage. In expansion stage participants with non-small cell lung cancer programmed death ligand -1 high (NSCLC PD L-1 high), NSCLC PD L-1 low, head and neck squamous cell carcinoma (HNSCC) PD L-1 positive, BRAF wild type (BRAF WT) melanoma and any locally advanced or metastatic solid tumors will be enrolled."
        },
        "conditionsModule": {
            "conditions": [
                "Advanced Solid Tumors",
                "Metastatic Solid Tumors"
            ]
        },
        "designModule": {
            "studyType": "INTERVENTIONAL",
            "phases": [
                "PHASE1"
            ],
            "designInfo": {
                "allocation": "NON_RANDOMIZED",
                "interventionModel": "SEQUENTIAL",
                "primaryPurpose": "TREATMENT",
                "maskingInfo": {
                    "masking": "NONE"
                }
            },
            "enrollmentInfo": {
                "count": 232,
                "type": "ESTIMATED"
            }
        },
        "armsInterventionsModule": {
            "armGroups": [
                {
                    "label": "Dose-finding Stage: GDC-1971",
                    "type": "EXPERIMENTAL",
                    "description": "Participants will receive GDC-1971 tablet or capsule at assigned dose, orally once daily (QD) on Days 1-21 of each cycle, along with atezolizumab 1200 milligrams (mg) intravenous (IV) infusion once every 3 weeks (Q3W), until unacceptable toxicity or loss of clinical benefit. A subset of participants will participate in evaluations regarding tablet versus (vs) capsule formulations.",
                    "interventionNames": [
                        "Drug: GDC-1971",
                        "Drug: Atezolizumab"
                    ]
                },
                {
                    "label": "Expansion Stage: GDC-1971",
                    "type": "EXPERIMENTAL",
                    "description": "Participants will receive GDC-1971 orally at the assigned dose QD on Days 1-21 of each cycle and atezolizumab 1200 mg IV on Day 1 of each cycle until unacceptable toxicity or loss of clinical benefit. A subset of participants will participate in evaluations regarding tablet vs capsule formulation, the effect of food and acid-reducing agents on GDC-1971.",
                    "interventionNames": [
                        "Drug: GDC-1971",
                        "Drug: Atezolizumab",
                        "Drug: Omeprazole"
                    ]
                }
            ],
            "interventions": [
                {
                    "type": "DRUG",
                    "name": "GDC-1971",
                    "description": "Capsule or tablet administered orally.",
                    "armGroupLabels": [
                        "Dose-finding Stage: GDC-1971",
                        "Expansion Stage: GDC-1971"
                    ],
                    "otherNames": [
                        "RO7517834, RLY-1971"
                    ]
                },
                {
                    "type": "DRUG",
                    "name": "Atezolizumab",
                    "description": "Administered as IV infusion.",
                    "armGroupLabels": [
                        "Dose-finding Stage: GDC-1971",
                        "Expansion Stage: GDC-1971"
                    ],
                    "otherNames": [
                        "RO5541267"
                    ]
                },
                {
                    "type": "DRUG",
                    "name": "Omeprazole",
                    "description": "Administered orally as tablet or capsule in the acid-reducing agent assessment.",
                    "armGroupLabels": [
                        "Expansion Stage: GDC-1971"
                    ]
                }
            ]
        },
        "outcomesModule": {
            "primaryOutcomes": [
                {
                    "measure": "Percentage of Participants With Adverse Events (AEs)",
                    "timeFrame": "Up to approximately 2.5 years"
                },
                {
                    "measure": "Percentage of Participants With Clinically Significant Change From Baseline in Vital Signs",
                    "timeFrame": "Baseline up to 30 days after final dose of study treatment (up approximately to 2.5 years)"
                },
                {
                    "measure": "Percentage of Participants With Clinically Significant Change from Baseline in Clinical Laboratory Test Results",
                    "timeFrame": "Baseline up to 30 days after final dose of study treatment (up approximately to 2.5 years)"
                },
                {
                    "measure": "Percentage of Participants With Clinically Significant Change From Baseline in RR and QT Intervals as Measured by Electrocardiogram (ECG)",
                    "timeFrame": "Baseline up to 30 days after final dose of study treatment (up approximately to 2.5 years)"
                },
                {
                    "measure": "Percentage of Participants Experiencing Dose Limiting Toxicities (DLTs)",
                    "timeFrame": "From Day 1 to Day 21 of Cycle 1 of the dose finding stage"
                },
                {
                    "measure": "Plasma Concentration of GDC-1971",
                    "timeFrame": "Up to approximately 2.5 years"
                }
            ],
            "secondaryOutcomes": [
                {
                    "measure": "Area Under the Concentration-Time Curve From Time 0 to 96 hours (AUC0-96 hr) Following GDC-1971 Capsule or Tablet Administration",
                    "timeFrame": "Up to approximately 2.5 years"
                },
                {
                    "measure": "AUC From Time 0 to Infinity (AUCinf) Following GDC-1971 Capsule or Tablet Administration",
                    "timeFrame": "Up to approximately 2.5 years"
                },
                {
                    "measure": "Cmax of GDC-1971 Following Capsule or Tablet Administration",
                    "timeFrame": "Up to approximately 2.5 years"
                },
                {
                    "measure": "AUC 0-96 hr Following GDC-1971 Tablet Administration Under Fasted and Fed Conditions",
                    "timeFrame": "Up to approximately 2.5 years"
                },
                {
                    "measure": "AUC inf Following GDC-1971 Tablet Administration Under Fasted and Fed Conditions",
                    "timeFrame": "Up to approximately 2.5 years"
                },
                {
                    "measure": "Cmax of GDC-1971 Following Tablet Administration Under Fasted and Fed Conditions",
                    "timeFrame": "Up to approximately 2.5 years"
                },
                {
                    "measure": "AUC 0-24 hr at Steady State Following GDC-1971 Tablet Administration and in Combination With Omeprazole",
                    "timeFrame": "Up to approximately 2.5 years"
                },
                {
                    "measure": "Cmax at Steady State Following GDC-1971 Tablet Administration and in Combination With Omeprazole",
                    "timeFrame": "Up to approximately 2.5 years"
                },
                {
                    "measure": "Objective Response Rate (ORR)",
                    "timeFrame": "Up to approximately 2.5 years"
                },
                {
                    "measure": "Duration of Response (DOR)",
                    "timeFrame": "Up to approximately 2.5 years"
                },
                {
                    "measure": "Progression Free Survival (PFS)",
                    "timeFrame": "Up to approximately 2.5 years"
                },
                {
                    "measure": "PFS Rate",
                    "timeFrame": "Month 6"
                },
                {
                    "measure": "Overall Survival (OS) Rate",
                    "timeFrame": "Months 6 and 12"
                }
            ]
        },
        "eligibilityModule": {
            "eligibilityCriteria": "Inclusion Criteria:\n\n* Has Eastern Cooperative Oncology Group(ECOG) Performance Status of 0 or 1\n* Has Life expectancy \\>= 12 weeks\n* Adequate organ function\n* Measurable disease per Response Evaluation Criteria in Solid Tumors, Version 1.1 (RECIST v1.1).\n\nInclusion Criteria for Dose-Finding Stage:\n\n* Histologically confirmed locally advanced or metastatic solid tumor that has progressed after at least one available standard therapy or for which approved standard therapy has proven to be ineffective or intolerable\n\nInclusion Criteria for Expansion Stage: NSCLC Cohort\n\n* Histologically confirmed locally advanced or metastatic NSCLC\n* Absence of epidermal growth factor receptor (EGFR) and anaplastic lymphoma kinase (ALK)\n* PD- L1 positive\n* No prior systemic therapy for locally advanced or metastatic NSCLC\n\nInclusion Criteria for Expansion Stage: HNSCC Cohort\n\n* Histologically confirmed recurrent, or metastatic HNSCC\n* PD-L1 positive\n* No prior systemic therapy for recurrent or metastatic HNSCC\n\nInclusion Criteria for Expansion Stage: BRAF WT melanoma Cohort\n\n* Histologically confirmed locally advanced or metastatic or unresectable locally advanced cutaneous BRAF WT melanoma or melanomas of unknown primary that are non-mucosal and non -uveal that has progressed on or after treatment that included anti PD1 or anti PD-L1 therapy\n\nInclusion Criteria for Expansion Stage: Other Advanced or Metastatic Solid Tumors Cohort\n\n* Histologically confirmed locally advanced or metastatic solid tumor that has progressed after at least one available standard therapy or for which approved standard therapy has proven to be ineffective or intolerable, standard therapy is considered inappropriate, or an investigational agent is a recognized standard of care\n\nExclusion Criteria:\n\n* Symptomatic, untreated, or actively progressing central nervous system (CNS) metastases.\n* Has leptomeningeal disease or carcinomatous meningitis\n* Has uncontrolled hypertension\n* Has left ventricular ejection fraction \\< institutional lower limit of normal or \\< 50%\n* Has clinically significant history of liver disease including viral or other hepatitis, current alcohol abuse, or cirrhosis\n* Has an active or history of autoimmune disease or immune deficiency including myasthenia gravis, myositis, autoimmune hepatitis, systemic lupus erythematosus, rheumatoid arthritis, inflammatory bowel disease, vascular thrombosis associated with antiphospholipid syndrome, Wegener's granulomatosis, Sj\u00f6gren's syndrome, Guillain-Barr\u00e9 syndrome, multiple sclerosis, vasculitis, or multiple sclerosis. Participants with a history of autoimmune- related hypothyroidism on thyroid replacement hormone or with controlled Type I diabetes mellitus on a stable dose of an insulin regimen are eligible for this study",
            "healthyVolunteers": false,
            "sex": "ALL",
            "minimumAge": "18 Years",
            "stdAges": [
                "ADULT",
                "OLDER_ADULT"
            ]
        },
        "contactsLocationsModule": {
            "centralContacts": [
                {
                    "name": "GO43712 https://forpatients.roche.com/",
                    "role": "CONTACT",
                    "phone": "888-662-6728 (U.S. Only)",
                    "email": "global-roche-genentech-trials@gene.com"
                }
            ],
            "overallOfficials": [
                {
                    "name": "Clinical Trials",
                    "affiliation": "Hoffmann-La Roche",
                    "role": "STUDY_DIRECTOR"
                }
            ],
            "locations": [
                {
                    "facility": "City of Hope",
                    "status": "RECRUITING",
                    "city": "Duarte",
                    "state": "California",
                    "zip": "91010",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 34.13945,
                        "lon": -117.97729
                    }
                },
                {
                    "facility": "Sanatorio Allende",
                    "status": "RECRUITING",
                    "city": "Cordoba",
                    "zip": "X5000JHQ",
                    "country": "Argentina",
                    "geoPoint": {
                        "lat": -31.4135,
                        "lon": -64.18105
                    }
                },
                {
                    "facility": "Fundacion CORI para la Investigacion y Prevencion del Cancer",
                    "status": "RECRUITING",
                    "city": "La Rioja",
                    "zip": "F5300COE",
                    "country": "Argentina",
                    "geoPoint": {
                        "lat": -29.41105,
                        "lon": -66.85067
                    }
                },
                {
                    "facility": "Centro Medico IPAM",
                    "status": "RECRUITING",
                    "city": "Rosario",
                    "zip": "S2013SBK",
                    "country": "Argentina",
                    "geoPoint": {
                        "lat": -32.94682,
                        "lon": -60.63932
                    }
                },
                {
                    "facility": "Centro de Investigaci\u00f3n Cl\u00ednica ? Cl\u00ednica Viedma",
                    "status": "RECRUITING",
                    "city": "Viedma",
                    "zip": "R8500ACE",
                    "country": "Argentina",
                    "geoPoint": {
                        "lat": -40.81345,
                        "lon": -62.99668
                    }
                },
                {
                    "facility": "St Vincent's Hospital Sydney",
                    "status": "RECRUITING",
                    "city": "Darlinghurst",
                    "state": "New South Wales",
                    "zip": "2010",
                    "country": "Australia",
                    "geoPoint": {
                        "lat": -33.87939,
                        "lon": 151.21925
                    }
                },
                {
                    "facility": "Border Medical Oncology",
                    "status": "RECRUITING",
                    "city": "Wodonga",
                    "state": "New South Wales",
                    "zip": "3690",
                    "country": "Australia",
                    "geoPoint": {
                        "lat": -36.12179,
                        "lon": 146.88809
                    }
                },
                {
                    "facility": "Flinders Medical Centre",
                    "status": "RECRUITING",
                    "city": "Bedford Park",
                    "state": "South Australia",
                    "zip": "5042",
                    "country": "Australia",
                    "geoPoint": {
                        "lat": -35.03333,
                        "lon": 138.56667
                    }
                },
                {
                    "facility": "Austin Hospital",
                    "status": "RECRUITING",
                    "city": "Heidelberg",
                    "state": "Victoria",
                    "zip": "3084",
                    "country": "Australia",
                    "geoPoint": {
                        "lat": -37.75,
                        "lon": 145.06667
                    }
                },
                {
                    "facility": "One Clinical Research Perth",
                    "status": "RECRUITING",
                    "city": "Nedlands",
                    "state": "Western Australia",
                    "zip": "6009",
                    "country": "Australia",
                    "geoPoint": {
                        "lat": -31.98184,
                        "lon": 115.8073
                    }
                },
                {
                    "facility": "Santa Casa de Misericordia de Belo Horizonte - PPDS",
                    "status": "RECRUITING",
                    "city": "Belo Horizonte",
                    "state": "MG",
                    "zip": "30150-221",
                    "country": "Brazil",
                    "geoPoint": {
                        "lat": -19.92083,
                        "lon": -43.93778
                    }
                },
                {
                    "facility": "Liga Paranaense de Combate Ao Cancer - Hospital Erasto Gaertner",
                    "status": "RECRUITING",
                    "city": "Curitiba",
                    "state": "PA",
                    "zip": "81520-060",
                    "country": "Brazil",
                    "geoPoint": {
                        "lat": -25.42778,
                        "lon": -49.27306
                    }
                },
                {
                    "facility": "Hospital de Clinicas de Porto Alegre HCPA PPDS",
                    "status": "RECRUITING",
                    "city": "Porto Alegre",
                    "state": "PA",
                    "zip": "90035-903",
                    "country": "Brazil",
                    "geoPoint": {
                        "lat": -30.03306,
                        "lon": -51.23
                    }
                },
                {
                    "facility": "Universidade de Caxias do Sul",
                    "status": "RECRUITING",
                    "city": "Caxias Do Sul",
                    "state": "RS",
                    "zip": "95070-561",
                    "country": "Brazil",
                    "geoPoint": {
                        "lat": -29.16806,
                        "lon": -51.17944
                    }
                },
                {
                    "facility": "ONCOSITE Centro de Pesquisa Cl\u00ednica Em Oncologia",
                    "status": "RECRUITING",
                    "city": "Iju\u00ed",
                    "state": "RS",
                    "zip": "98700-000",
                    "country": "Brazil",
                    "geoPoint": {
                        "lat": -28.38778,
                        "lon": -53.91472
                    }
                },
                {
                    "facility": "Funda\u00e7\u00e3o Doutor Amaral Carvalho - Hospital Amaral",
                    "status": "RECRUITING",
                    "city": "JAU",
                    "state": "SP",
                    "zip": "17210-080",
                    "country": "Brazil",
                    "geoPoint": {
                        "lat": -22.29639,
                        "lon": -48.55778
                    }
                },
                {
                    "facility": "Fundacao Faculdade Regional de Medicina de Sao Jose Do Rio Preto Hospital de Base - PPDS",
                    "status": "RECRUITING",
                    "city": "Sao Jose Do Rio Preto",
                    "state": "SP",
                    "zip": "15090-000",
                    "country": "Brazil",
                    "geoPoint": {
                        "lat": -20.81972,
                        "lon": -49.37944
                    }
                },
                {
                    "facility": "Instituto do Cancer do Estado de Sao Paulo - ICESP",
                    "status": "RECRUITING",
                    "city": "Sao Paulo",
                    "state": "SP",
                    "zip": "01246-000",
                    "country": "Brazil",
                    "geoPoint": {
                        "lat": -23.5475,
                        "lon": -46.63611
                    }
                },
                {
                    "facility": "Instituto Brasileiro de Controle Do C\u00e2ncer IBCC",
                    "status": "RECRUITING",
                    "city": "S\u00e3o Paulo",
                    "state": "SP",
                    "zip": "03102-006",
                    "country": "Brazil",
                    "geoPoint": {
                        "lat": -23.5475,
                        "lon": -46.63611
                    }
                },
                {
                    "facility": "Cross Cancer Institute",
                    "status": "RECRUITING",
                    "city": "Edmonton",
                    "state": "Alberta",
                    "zip": "T6G 1Z2",
                    "country": "Canada",
                    "geoPoint": {
                        "lat": 53.55014,
                        "lon": -113.46871
                    }
                },
                {
                    "facility": "Ottawa Hospital",
                    "status": "RECRUITING",
                    "city": "Ottawa",
                    "state": "Ontario",
                    "zip": "K1H 8L6",
                    "country": "Canada",
                    "geoPoint": {
                        "lat": 45.41117,
                        "lon": -75.69812
                    }
                },
                {
                    "facility": "Princess Margaret Cancer Centre",
                    "status": "RECRUITING",
                    "city": "Toronto",
                    "state": "Ontario",
                    "zip": "M5G 1Z5",
                    "country": "Canada",
                    "geoPoint": {
                        "lat": 43.70011,
                        "lon": -79.4163
                    }
                },
                {
                    "facility": "Chungbuk National University Hospital",
                    "status": "RECRUITING",
                    "city": "Cheongju si",
                    "zip": "28644",
                    "country": "Korea, Republic of",
                    "geoPoint": {
                        "lat": 36.63722,
                        "lon": 127.48972
                    }
                },
                {
                    "facility": "National Cancer Center",
                    "status": "RECRUITING",
                    "city": "Goyang-si",
                    "zip": "10408",
                    "country": "Korea, Republic of",
                    "geoPoint": {
                        "lat": 37.65639,
                        "lon": 126.835
                    }
                },
                {
                    "facility": "Seoul National University Hospital",
                    "status": "RECRUITING",
                    "city": "Seoul",
                    "zip": "03080",
                    "country": "Korea, Republic of",
                    "geoPoint": {
                        "lat": 37.566,
                        "lon": 126.9784
                    }
                },
                {
                    "facility": "Severance Hospital, Yonsei University Health System",
                    "status": "RECRUITING",
                    "city": "Seoul",
                    "zip": "03722",
                    "country": "Korea, Republic of",
                    "geoPoint": {
                        "lat": 37.566,
                        "lon": 126.9784
                    }
                },
                {
                    "facility": "Asan Medical Center - PPDS",
                    "status": "RECRUITING",
                    "city": "Seoul",
                    "zip": "05505",
                    "country": "Korea, Republic of",
                    "geoPoint": {
                        "lat": 37.566,
                        "lon": 126.9784
                    }
                },
                {
                    "facility": "The Catholic University of Korea Seoul St. Mary?s Hospital",
                    "status": "RECRUITING",
                    "city": "Seoul",
                    "zip": "6591",
                    "country": "Korea, Republic of",
                    "geoPoint": {
                        "lat": 37.566,
                        "lon": 126.9784
                    }
                },
                {
                    "facility": "The Catholic University of Korea St. Vincent's Hospital",
                    "status": "RECRUITING",
                    "city": "Suwon",
                    "zip": "442-723",
                    "country": "Korea, Republic of",
                    "geoPoint": {
                        "lat": 37.29111,
                        "lon": 127.00889
                    }
                },
                {
                    "facility": "Auckland City Hospital",
                    "status": "RECRUITING",
                    "city": "Auckland",
                    "zip": "1124",
                    "country": "New Zealand",
                    "geoPoint": {
                        "lat": -36.84853,
                        "lon": 174.76349
                    }
                },
                {
                    "facility": "Uniwersytecki Szpital Kliniczny w Poznaniu",
                    "status": "WITHDRAWN",
                    "city": "Pozna?",
                    "zip": "60-335",
                    "country": "Poland",
                    "geoPoint": {
                        "lat": 51.84442,
                        "lon": 14.61868
                    }
                },
                {
                    "facility": "NEXT Oncology-Hospital Quironsalud Madrid",
                    "status": "WITHDRAWN",
                    "city": "Pozuelo de Alarcon",
                    "state": "Madrid",
                    "zip": "28223",
                    "country": "Spain",
                    "geoPoint": {
                        "lat": 40.43293,
                        "lon": -3.81338
                    }
                },
                {
                    "facility": "Clinica Universidad de Navarra",
                    "status": "WITHDRAWN",
                    "city": "Pamplona",
                    "state": "Navarra",
                    "zip": "31008",
                    "country": "Spain",
                    "geoPoint": {
                        "lat": 42.81687,
                        "lon": -1.64323
                    }
                },
                {
                    "facility": "Hospital de la Santa Creu i Sant Pau",
                    "status": "WITHDRAWN",
                    "city": "Barcelona",
                    "zip": "08025",
                    "country": "Spain",
                    "geoPoint": {
                        "lat": 41.38879,
                        "lon": 2.15899
                    }
                },
                {
                    "facility": "MD Anderson Cancer Center Madrid ? Espana",
                    "status": "WITHDRAWN",
                    "city": "Madrid",
                    "zip": "28033",
                    "country": "Spain",
                    "geoPoint": {
                        "lat": 40.4165,
                        "lon": -3.70256
                    }
                },
                {
                    "facility": "Hospital Universitario Ramon y Cajal",
                    "status": "WITHDRAWN",
                    "city": "Madrid",
                    "zip": "28034",
                    "country": "Spain",
                    "geoPoint": {
                        "lat": 40.4165,
                        "lon": -3.70256
                    }
                },
                {
                    "facility": "Clinica Universitaria Navarra (Madrid)",
                    "status": "WITHDRAWN",
                    "city": "Madrid",
                    "zip": "28036",
                    "country": "Spain",
                    "geoPoint": {
                        "lat": 40.4165,
                        "lon": -3.70256
                    }
                },
                {
                    "facility": "Hospital Universitario Virgen del Rocio",
                    "status": "WITHDRAWN",
                    "city": "Sevilla",
                    "zip": "41013",
                    "country": "Spain",
                    "geoPoint": {
                        "lat": 37.38283,
                        "lon": -5.97317
                    }
                },
                {
                    "facility": "Hospital Universitario Virgen Macarena",
                    "status": "WITHDRAWN",
                    "city": "Sevilla",
                    "zip": "41013",
                    "country": "Spain",
                    "geoPoint": {
                        "lat": 37.38283,
                        "lon": -5.97317
                    }
                },
                {
                    "facility": "Hospital Clinico Universitario de Valencia",
                    "status": "WITHDRAWN",
                    "city": "Valencia",
                    "zip": "46010",
                    "country": "Spain",
                    "geoPoint": {
                        "lat": 39.46975,
                        "lon": -0.37739
                    }
                }
            ]
        },
        "ipdSharingStatementModule": {
            "ipdSharing": "YES",
            "description": "Qualified researchers may request access to individual patient level data through the clinical study data request platform (www.vivli.org). Further details on Roche's criteria for eligible studies are available here (https://vivli.org/ourmember/roche/). For further details on Roche's Global Policy on the Sharing of Clinical Information and how to request access to related clinical study documents, see here (https://www.roche.com/research_and_development/who_we_are_how_we_work/clinical_trials/our_commitment_to_data_sharing.htm).",
            "infoTypes": [
                "STUDY_PROTOCOL",
                "SAP",
                "CSR"
            ]
        }
    },
    "derivedSection": {
        "miscInfoModule": {
            "versionHolder": "2024-07-30"
        },
        "conditionBrowseModule": {
            "meshes": [
                {
                    "id": "D000009369",
                    "term": "Neoplasms"
                }
            ]
        },
        "interventionBrowseModule": {
            "meshes": [
                {
                    "id": "C000594389",
                    "term": "Atezolizumab"
                },
                {
                    "id": "D000009853",
                    "term": "Omeprazole"
                }
            ],
            "ancestors": [
                {
                    "id": "D000082082",
                    "term": "Immune Checkpoint Inhibitors"
                },
                {
                    "id": "D000045504",
                    "term": "Molecular Mechanisms of Pharmacological Action"
                },
                {
                    "id": "D000074322",
                    "term": "Antineoplastic Agents, Immunological"
                },
                {
                    "id": "D000000970",
                    "term": "Antineoplastic Agents"
                },
                {
                    "id": "D000000897",
                    "term": "Anti-Ulcer Agents"
                },
                {
                    "id": "D000005765",
                    "term": "Gastrointestinal Agents"
                },
                {
                    "id": "D000054328",
                    "term": "Proton Pump Inhibitors"
                },
                {
                    "id": "D000004791",
                    "term": "Enzyme Inhibitors"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M12785",
                    "name": "Omeprazole",
                    "asFound": "2 days",
                    "relevance": "HIGH"
                },
                {
                    "id": "M349417",
                    "name": "Atezolizumab",
                    "asFound": "Status",
                    "relevance": "HIGH"
                },
                {
                    "id": "M2342",
                    "name": "Immune Checkpoint Inhibitors",
                    "relevance": "LOW"
                },
                {
                    "id": "M1346",
                    "name": "Antineoplastic Agents, Immunological",
                    "relevance": "LOW"
                },
                {
                    "id": "M4188",
                    "name": "Antacids",
                    "relevance": "LOW"
                },
                {
                    "id": "M4219",
                    "name": "Anti-Ulcer Agents",
                    "relevance": "LOW"
                },
                {
                    "id": "M8881",
                    "name": "Gastrointestinal Agents",
                    "relevance": "LOW"
                },
                {
                    "id": "M27630",
                    "name": "Proton Pump Inhibitors",
                    "relevance": "LOW"
                },
                {
                    "id": "M7951",
                    "name": "Enzyme Inhibitors",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "Gast",
                    "name": "Gastrointestinal Agents"
                },
                {
                    "abbrev": "All",
                    "name": "All Drugs and Chemicals"
                },
                {
                    "abbrev": "ANeo",
                    "name": "Antineoplastic Agents"
                }
            ]
        }
    },
    "hasResults": false
}